Stephen Opat

Adjunct Prof

1995 …2025

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Stephen Opat is the director of Clinical Haematology at Monash Health, a dynamic academic research organization that integrates the best evidence–base into routine patient care. It provides haematology care to a population of approximately 1.3 million, making it one of the largest services in Australia.  Key leadership areas in clinical care and research include: Lymphoid cancer, chronic myeloid disorders, thromboembolic disease, haemoglobinopathy and transfusion medicine. It is an active member of a number of research organisations including the Monash Health Translation Precinct (MHTP), the Centre for Cancer Research (CCR) at the Hudson Institute of Medical Research, and the Australasian Leukaemia and Lymphoma Group. His particular interests include the diagnosis and management of lymphoma and chronic lymphocytic leukaemia, cancer genomics, disorders of iron metabolism, Gaucher disease and novel therapies. He is the principal investigator in over 30 clinical trials mainly in lymphoid cancer and founder of the Australasian Lymphoma and Related Diseases Registry. He has a strong interest in medical education, particularly in developing countries, and has lectured widely throughout the Asia-Pacific. He is extremely active in the Haematology Society of Australia and New Zealand where he currently serves as President.

Research area keywords

  • Lymphoma
  • Genomics
  • Chronic Lymphocytic Leukaemia
  • Cancer Immunology
  • Cancer Cell Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma

Ng, Z. Y., Bishton, M., Ritchie, D., Campbell, R., Gilbertson, M., Hill, K., Ratnasingam, S., Schwarer, A., Manos, K., Shorten, S., Ng, M., Nelson, N., Xin, L., De Mel Widanalage, S., Sunny, T., Purtill, D., Poon, M., Johnston, A., Cochrane, T., Lee, H. P. & 6 others, Hapgood, G., Tam, C., Opat, S., Hawkes, E., Seymour, J. & Cheah, C. Y., Aug 2019, In : Hematological Oncology. 37, 3, p. 253-260 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Author reply

Trotman, J., Cheah, C. Y., Marlton, P. & Opat, S., 1 Oct 2019, In : Internal Medicine Journal. 49, 10, p. 1338-1339 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Bleeding and thrombotic events occur early in children on durable ventricular assist devices

Huang, J. Y., Ignjatovic, V., Sheridan, B. J., Mathew, J., D'Udekem, Y., Brink, J., Barton, R., Callea, G., Morsman, D., Donath, S., Opat, S. & Monagle, P., 1 Jan 2019, In : Thrombosis Research. 173, p. 65-70 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma

Ratnasingam, S., Casan, J., Shortt, J., Hawkes, E., Gilbertson, M., McQuilten, Z., Grigoriadis, G., Htun, K. T., Htet, S. M., Campbell, P., Chai, K. L., Quach, H., Patil, S. & Opat, S., 19 Sep 2019, In : Scientific Reports. 9, 1, 7 p., 13544.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Management of patients with follicular lymphoma treated first line with obinutuzumab

Opat, S., Dickinson, M., Cheah, C. Y., Tam, C., Boulos, J., Thorburn, A. N. & Trotman, J., 1 May 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, S3, p. 3-11 9 p.

Research output: Contribution to journalArticleResearchpeer-review